Corcept Therapeutics Incorporated · NASDAQ:CORT
Joseph K. Belanoff reported a 6.30% stake in Corcept Therapeutics Incorporated (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Joseph K. Belanoff reported a 6.30% stake in Corcept Therapeutics Incorporated, 6,822,335 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.30%
- Shares
- 6,822,335
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Joseph K. Belanoff | 6.30% | 6,822,335 |